In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria
- 1 March 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (3), 455-457
- https://doi.org/10.1128/aac.31.3.455
Abstract
The in vitro activity of LY146032, a novel cyclic lipopeptide antibiotic, was tested against different gram-positive clinical isolates. The activity of LY146032 was clearly higher than that of vancomycin against all isolates tested. However, in some instances rifampin and imipenem showed higher activity than did LY146032.This publication has 5 references indexed in Scilit:
- Usefulness of a Test for Slime Production as a Marker for Clinically Significant Infections with Coagulase-Negative StaphylococciThe Journal of Infectious Diseases, 1986
- In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1985
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978